New Frontier completes acquisition of Hong Kong Integrated Oncology Centre

Through the acquisition, HKIOC will collaborate with the group’s other subsidiaries.

The New Frontier Group, a private healthcare service provider in China, has acquired the Hong Kong Integrated Oncology Centre (HKIOC).

Through the acquisition, the group will own HKIOC’s operations, including the Hong Kong Adventist Hospital Oncology Centre and the HKIOC Centres in Hong Kong Island and Kowloon.

Moreover, HKIOC will collaborate with the group’s subsidiaries, particularly HEAL Oncology and United Family Healthcare to advance cross-border cancer care.

ALSO READ: Swire Pacific acquires controlling stake in DeltaHealth

"We will leverage synergies across our subsidiaries to create an advanced and robust healthcare ecosystem,” Carl Wu, group CEO and co-founder of New Frontier Group, said.

“The acquisition of HKIOC gives us incredible depth of expertise to treat the most common, as well as the rarest forms of cancer,” Wu added.